Subscribe
Subscribe
Home Tags Pfizer

Tag: Pfizer

Pfizer wins third case over subsidiary’s asbestos-containing product

Pfizer wins third case over subsidiary’s asbestos-containing product

Heather Isringhausen Gvillo -
0
Third Circuit dismisses securities class action lawsuit against Pfizer
Healthcare

Third Circuit dismisses securities class action lawsuit against Pfizer

Kyla Asbury -
0
In this May 4, 2014 photo, the Pfizer logo is displayed on the exterior of a former Pfizer factory in the Brooklyn borough of New York. Pfizer says it does not intend to make a takeover offer for British drugmaker AstraZeneca. The Monday, May 26, 2014 announcement comes a week after AstraZeneca's board rejected a proposed $119 billion buyout offer from Pfizer, the world's second-biggest drugmaker by revenue. (AP Photo/Mark Lennihan, File)
Business

Pfizer pulls plug on push to buy AstraZeneca

Alex Veiga -
0
FILE - This Friday May 2, 2014 file photo shows an exterior view of the Two Kingdom Street building which houses the headquarters of AstraZeneca, in the Paddington area of London. The board of AstraZeneca has rejected the improved $119 billion takeover offer from U.S. drugmaker Pfizer, Monday May 19, 2014, a decision that has caused a sharp slide in the U.K. company's share price as investors think it effectively brings an end to the protracted and increasingly bitter takeover saga. (AP Photo/Matt Dunham, File)
Business

AstraZeneca rejects $119 billion offer from Pfizer

Washington Examiner -
0
Pfizer raises offer, highlighting flurry of deals
Business

Pfizer raises offer, highlighting flurry of deals

The Associated Press -
0
Board of British drugmaker AstraZeneca rejects new $119 billion takeover offer from Pfizer
Business

Board of British drugmaker AstraZeneca rejects new $119 billion takeover offer from Pfizer

Washington Examiner -
0
Pfizer ups offer for AstraZeneca again, to $119B
Business

Pfizer ups offer for AstraZeneca again, to $119B

Linda Johnson -
0
Pfizer chief says jobs will go in takeover
Business

Pfizer chief says jobs will go in takeover

Danica Kirka -
0
An exterior view of the Two Kingdom Street building which houses the headquarters of AstraZeneca, in the Paddington area of London, Friday, May 2, 2014. The board of pharmaceutical company AstraZeneca on Friday rejected drug maker Pfizer's sweetened takeover offer. Pfizer earlier in the day said it is offering 50 pounds ($84) a share in cash and stock, a 7.3 increase on a previous bid. The offer values AstraZeneca at $106 billion. (AP Photo/Matt Dunham)
Business

AstraZeneca rejects sweetened Pfizer takeover bid

DANICA KIRKALINDA A. JOHNSON -
0
AstraZeneca board rejects sweetened takeover offer from Pfizer
Business

AstraZeneca board rejects sweetened takeover offer from Pfizer

Washington Examiner -
0
1...333435Page 34 of 35
Do Not Sell or Share My Personal Information

NEWS

POLICY

COMMENTARY

RESTORING AMERICA